Table 6. Pathway mapping of differentially abundant plasma metabolites (p < 0.005).
| Pathway Name | Pathway DB | p-value |
|---|---|---|
| Acyl chain remodeling of CL | Reactome | 0.0049 |
| Acyl chain remodelling of PC | Reactome | 0.0049 |
| Ca-dependent events | Reactome | 0.0049 |
| Choline metabolism in cancer - Homo sapiens (human) | KEGG | 0.0049 |
| Fcgamma receptor (FCGR) dependent phagocytosis | Wikipathways | 0.0049 |
| Glycerophospholipid metabolism - Homo sapiens (human) | KEGG | 0.0049 |
| G-protein mediated events | Reactome | 0.0049 |
| HDL-mediated lipid transport | Reactome | 0.0049 |
| Linoleate metabolism | EHMN | 0.0049 |
| Lipid digestion, mobilization, and transport | Wikipathways | 0.0049 |
| Lipid digestion, mobilization, and transport | Reactome | 0.0049 |
| Lipoprotein metabolism | Reactome | 0.0049 |
| Opioid Signalling | Reactome | 0.0049 |
| Opioid Signalling | Wikipathways | 0.0049 |
| Phospholipid Biosynthesis | SMPDB | 0.0049 |
| phospho-PLA2 pathway | Reactome | 0.0049 |
| PLC beta mediated events | Reactome | 0.0049 |
Pathway overrepresention for those metabolites with known identities that differed at < 1% FDR.